Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual MeetingGlobeNewsWire • 05/14/20
Corcept Therapeutics Shows Rising Price Performance With Jump To 85 RS RatingInvestors Business Daily • 05/06/20
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/05/20
Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/04/20
Are You Looking for a Top Momentum Pick? Why Corcept Therapeutics (CORT) is a Great ChoiceZacks Investment Research • 04/27/20
CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETYGlobeNewsWire • 04/01/20
Corcept (CORT) Down 24.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/21/20
Corcept Therapeutics, Inc. (CORT) CEO Joseph Belanoff on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/21/20
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue GuidanceGlobeNewsWire • 01/30/20
Despite The Clouds Hanging Over Korlym Sales, Corcept Therapeutics Still Looks An Attractive InvestmentSeeking Alpha • 01/17/20